ライフサイエンスコーパス: carotid endarterectomy

1 ho had carotid artery stenting, 1105 who had carotid endarterectomy).

2 SMCs and atherosclerotic plaques obtained at carotid endarterectomy.

3 treated with carotid artery stenting versus carotid endarterectomy.

4 ocated to receive carotid artery stenting or carotid endarterectomy.

5 llation, and absence of previous ipsilateral carotid endarterectomy.

6 nly after carotid artery stenting than after carotid endarterectomy.

7 MI and biomarker+ only were more common with carotid endarterectomy.

8 immunohistochemistry for patients undergoing carotid endarterectomy.

9 fell for coronary-artery bypass grafting and carotid endarterectomy.

10 her risk of myocardial infarction (MI) after carotid endarterectomy.

11 ratio to receive carotid artery stenting or carotid endarterectomy.

12 fety of carotid artery stenting with that of carotid endarterectomy.

13 oke would improve the risk-benefit ratio for carotid endarterectomy.

14 tid-artery stenting and the group undergoing carotid endarterectomy.

15 enosis to undergo carotid-artery stenting or carotid endarterectomy.

16 es were obtained from patients who underwent carotid endarterectomy.

17 y, coronary artery bypass graft surgery, and carotid endarterectomy.

18 emoral carotid artery stenting compared with carotid endarterectomy.

19 eems to be similar to timing of stroke after carotid endarterectomy.

20 suggest that outcomes may approach those of carotid endarterectomy.

21 rd deviation]) who were scheduled to undergo carotid endarterectomy.

22 event within the previous 5 days) undergoing carotid endarterectomy.

23 mesenteric and renal revascularization, and carotid endarterectomy.

24 emboli-protection device is not inferior to carotid endarterectomy.

25 were collected from 159 patients undergoing carotid endarterectomy.

26 nvolved in cerebral hyperperfusion following carotid endarterectomy.

27 omised controlled trial of patients awaiting carotid endarterectomy.

28 Stent Trial comparing carotid stenting with carotid endarterectomy.

29 dural complication rates similar to those of carotid endarterectomy.

30 giography in most patients examined prior to carotid endarterectomy.

31 nt has emerged as a potential alternative to carotid endarterectomy.

32 lective infrarenal aortic reconstruction and carotid endarterectomy.

33 sus adjacent media of 13 patients undergoing carotid endarterectomy.

34 70-99% carotid stenosis may not benefit from carotid endarterectomy.

35 d arteries in a group of patients undergoing carotid endarterectomy.

36 haracteristics and outcome in men undergoing carotid endarterectomy.

37 in healthy controls and patients undergoing carotid endarterectomy.

38 betic and 30 nondiabetic patients undergoing carotid endarterectomy.

39 artery stenosis most likely to benefit from carotid endarterectomy.

40 netic resonance imaging, 46.9% (n=15) before carotid endarterectomy.

41 tic plaques removed from patients undergoing carotid endarterectomy.

42 ed with swelling in his left neck after left carotid endarterectomy.

43 oke after carotid artery stenting than after carotid endarterectomy.

44 s, ranging from a relative decline of 8% for carotid endarterectomy (1.3% mortality in 1999 and 1.2%

45 g compared with 16 (3.8%) of 417 assigned to carotid endarterectomy (1.84, 1.01-3.37; interaction p=0

46 nt vs. 3.8 percent) to only 0.2 percent (for carotid endarterectomy, 1.7 percent vs. 1.5 percent).

47 dicted an increased rate of restenosis after carotid endarterectomy (2.26, 1.34-3.77) but not after c

48 ting (Kaplan-Meier rate 6.0%) and 62 who had carotid endarterectomy (6.3%) had restenosis or occlusio

49 common procedures were herniorrhaphy (10%), carotid endarterectomy (6.6%), and open colectomy (5.6%)

50 Of 366 patients with carotid endarterectomy, 61 exhibited some degree of LOY

51 Of the treated vessels, 59 (22%) had prior carotid endarterectomy, 66 (24%) had ulcerated plaques,

52 ween IVSR and VSF-trained surgeons following carotid endarterectomy (8%-IVSR vs. 7%-VSF), lower extre

53 ion to stroke or death in patients receiving carotid endarterectomy, a harm of screening included the

54 domly assigned to carotid artery stenting or carotid endarterectomy (Abbott Vascular).

55 Before carotid endarterectomy, all patients underwent positron

56 with high-grade stenosis derive benefit from carotid endarterectomy, although they have different ris

57 Almost half (47.5%) of the carotid endarterectomies among Ohio's Medicare populatio

58 grated with gene expression profiling of 121 carotid endarterectomies and an analysis of protein secr

59 rosclerotic lesions from each of 13 cases of carotid endarterectomy and 16 lower limb amputations and

60 ients with culprit carotid stenosis awaiting carotid endarterectomy and 8 controls without culprit ca

61 Carotid endarterectomy and carotid artery stenting are t

62 disease burden in women, review outcomes of carotid endarterectomy and carotid artery stenting in wo

63 for management include antiplatelet therapy, carotid endarterectomy and carotid artery stenting.

64 t and rates were similar up to 2 years after carotid endarterectomy and carotid artery stenting.

65 Carotid endarterectomy and carotid artery stenting.

66 well as that of an intraoperative monitor in carotid endarterectomy and carotid stenting.

67 The potential for expanded indications for carotid endarterectomy and development of percutaneous t

68 monocytes purified from patients undergoing carotid endarterectomy and normal subjects by using the

69 Human plaques were derived from carotid endarterectomy and stained against P2X7.

70 tional trends in performance and outcomes of carotid endarterectomy and stenting among Medicare benef

71 mpared included immediate revascularization (carotid endarterectomy) and ongoing medical therapy (wit

72 going open abdominal aortic aneurysm repair, carotid endarterectomies, and peripheral vascular operat

73 rction, revascularization procedure, stroke, carotid endarterectomy, and amputation in CHOICE; and as

74 ry disease are optimizing medical treatment, carotid endarterectomy, and carotid artery stenting.

75 on, anesthetic technique, and monitoring for carotid endarterectomy, and durability of stenting and a

76 t that carotid stenting may be comparable to carotid endarterectomy, and it underscores the clinical

77 ous comorbid conditions are at high risk for carotid endarterectomy, and may be safely treated by car

78 These signals are particularly common after carotid endarterectomy, and this provides a situation in

79 We examined rates of CABG, carotid endarterectomy, and total hip replacement in 158

80 res: coronary-artery bypass grafting (CABG), carotid endarterectomy, and total hip replacement.

81 m of stroke to target interventions, such as carotid endarterectomy, anticoagulation for atrial fibri

82 ssion medications on all patients undergoing carotid endarterectomy, aortic surgery, or lower extremi

83 grafting, abdominal aortic aneurysm repair, carotid endarterectomy, aortic valve replacement, esopha

84 Carotid-artery stenting and carotid endarterectomy are both options for treating car

85 ars of age, and at standard or high risk for carotid endarterectomy are eligible for enrollment.

86 Carotid endarterectomy can be safely performed in a comm

87 The rates of carotid endarterectomy, cardiac catheterization, coronar

88 carotid stenosis and high-risk features for carotid endarterectomy, carotid artery stenting with dis

89 ACAS) showed significant risk reductions for carotid endarterectomy (CE) but did not consider the cos

90 Carotid endarterectomy (CE) has been shown to be more ef

91 of carotid artery stenting (CAS) relative to carotid endarterectomy (CEA) among Medicare patients has

92 me and the risk of stroke or death following carotid endarterectomy (CEA) and carotid artery stenting

93 -day readmission between patients undergoing carotid endarterectomy (CEA) and carotid artery stenting

94 In patients with carotid artery disease, carotid endarterectomy (CEA) and carotid stenting (CAS)

95 roke affects 2% to 3% of patients undergoing carotid endarterectomy (CEA) and is preceded by 1 to 2 h

96 procedural ischemic DWI lesions after CAS or carotid endarterectomy (CEA) are associated with an incr

97 data after carotid artery stenting (CAS) and carotid endarterectomy (CEA) are lacking.

98 The outcome of standard longitudinal carotid endarterectomy (CEA) can be measured by preserva

99 rk trials excluding dialysis patients showed carotid endarterectomy (CEA) decreased stroke risk compa

100 Staged carotid endarterectomy (CEA) followed by OHS or combined

101 ative stroke is a persistent complication of carotid endarterectomy (CEA) for patients with symptomat

102 her after carotid artery stenting (CAS) than carotid endarterectomy (CEA) for the treatment of sympto

103 abdominal aortic aneurysm (AAA) repair, and carotid endarterectomy (CEA) from 1998 to 2001 using the

104 Recurrent stenosis after carotid endarterectomy (CEA) has been reported to vary b

105 Carotid endarterectomy (CEA) has been shown to be more e

106 Carotid endarterectomy (CEA) has clearly been shown to b

107 ioplasty and stenting (CAS) is equivalent to carotid endarterectomy (CEA) in patients with symptomati

108 is Study (ACAS) demonstrated the efficacy of carotid endarterectomy (CEA) in reducing the risk of str

109 d Atherosclerosis Study (ACAS) reported that carotid endarterectomy (CEA) is beneficial for patients

110 Carotid endarterectomy (CEA) is still considered the gol

111 Carotid endarterectomy (CEA) is supported by level 1 evi

112 Although carotid endarterectomy (CEA) is the established gold sta

113 of asymptomatic carotid artery stenosis with carotid endarterectomy (CEA) or carotid angioplasty and

114 en proposed as determinants of outcome after carotid endarterectomy (CEA) or carotid artery stenting

115 alent risk of major adverse events following carotid endarterectomy (CEA) or carotid artery stenting

116 Given the controversy regarding whether carotid endarterectomy (CEA) or carotid artery stenting

117 dentify articles comparing early outcomes of carotid endarterectomy (CEA) or carotid stenting (CAS) i

118 Carotid revascularization with carotid endarterectomy (CEA) or stenting (CAS) is freque

119 The benefit of carotid endarterectomy (CEA) over medical therapy in pat

120 invasive alternative for high-risk surgical carotid endarterectomy (CEA) patients.

121 n abdominal aortic aneurysm repair (OAR) and carotid endarterectomy (CEA) performed by very low-volum

122 omparative studies of medical therapy alone, carotid endarterectomy (CEA) plus medical therapy, or ca

123 or other neurological symptoms), successful carotid endarterectomy (CEA) reduces stroke incidence fo

124 It is generally accepted that carotid endarterectomy (CEA) reduces the risk of stroke

125 ate can be administered at the conclusion of carotid endarterectomy (CEA) to reverse the anticoagulan

126 f surgical risks and long-term benefits from carotid endarterectomy (CEA) was unclear.

127 al demonstrated that CAS was not inferior to carotid endarterectomy (CEA) when performed by physician

128 g (CAS) has achieved clinical equipoise with carotid endarterectomy (CEA), as evidenced by 2 large U.

129 tomy, vascular infrainguinal reconstruction, carotid endarterectomy (CEA), lung lobectomy/pneumonecto

130 comparing carotid artery stenting (CAS) and carotid endarterectomy (CEA), with better CEA outcomes t

131 ndrome (CHS) is an important complication of carotid endarterectomy (CEA), yet prior research has bee

132 ed with carotid artery stenting (CAS) versus carotid endarterectomy (CEA).

133 ported after carotid artery stenting CAS and carotid endarterectomy (CEA).

134 ation in patients who subsequently underwent carotid endarterectomy (CEA).

135 oing carotid duplex imaging before and after carotid endarterectomy (CEA).

136 of patients with carotid artery stenosis for carotid endarterectomy (CEA).

137 abdominal aortic aneurysm [AAA] repairs, 100 carotid endarterectomies [CEA], and 7 esophagectomies an

138 ntly referred for carotid revascularization (carotid endarterectomy [CEA] or CS) based on the results

139 At present, carotid endarterectomy combined with optimal drug therap

140 Risks of stroke and complications from carotid endarterectomy, costs, and quality of life value

141 e Medicare beneficiaries, the performance of carotid endarterectomy declined from 1999 to 2014, where

142 es (n=10) collected from patients undergoing carotid endarterectomy demonstrated that subsets of lipi

143 ysm repair, coronary artery bypass grafting, carotid endarterectomy, esophageal cancer resection, hip

144 underwent elective major vascular surgery - carotid endarterectomy, EVAR, open AAA repair, bypass fo

145 challenges presented by patients undergoing carotid endarterectomy, excellent outcomes have been ach

146 In this time of evidence-based medicine, carotid endarterectomy fares badly, with only the indica

147 urified these cells from patients undergoing carotid endarterectomy for advanced atherosclerosis and

148 th or without stenting) is an alternative to carotid endarterectomy for carotid artery stenosis but t

149 th duplex ultrasonography and treatment with carotid endarterectomy for CAS.

150 hy, and the intervention in the 3 trials was carotid endarterectomy for patients with stenosis exceed

151 on and specific risk factors; and performing carotid endarterectomy for patients with stenosis of at

152 anticoagulation for atrial fibrillation and carotid endarterectomy for severe symptomatic carotid ar

153 Carotid endarterectomy for stroke prevention has been th

154 The risk of stroke or death associated with carotid endarterectomy for symptomatic carotid stenosis

155 Stents are an alternative treatment to carotid endarterectomy for symptomatic carotid stenosis,

156 t differ between carotid artery stenting and carotid endarterectomy for symptomatic or asymptomatic c

157 of recent data indicates a clear benefit of carotid endarterectomy for symptomatic patients with hig

158 emboli-protection device is not inferior to carotid endarterectomy for the treatment of carotid arte

159 a less invasive percutaneous procedure than carotid endarterectomy for the treatment of carotid sten

160 tor (GIPR) and OPN mRNA levels are higher in carotid endarterectomies from patients with symptoms (st

161 This effect was driven by a decrease in the carotid endarterectomy group (unadjusted odds ratio per

162 allocated to carotid artery stenting, 500 to carotid endarterectomy) had baseline imaging available.

163 platelet therapy, anticoagulant therapy, and carotid endarterectomy have all proven to be effective i

164 red in carotid artery stenting and 28 MIs in carotid endarterectomy (hazard ratio, 0.50; 95% confiden

165 of mortality were smoking history, previous carotid endarterectomy, hemoglobin level, and increasing

166 g compared with 40 (4.9%) of 823 assigned to carotid endarterectomy (HR 0.90, 95% CI 0.57-1.41) and 3

167 similar association in patients treated with carotid endarterectomy (HR for any stroke 1.18, 0.40-3.5

168 teral middle cerebral artery were made after carotid endarterectomy in 12 control patients and 12 pat

169 ith IPH on MR images would undergo immediate carotid endarterectomy in addition to ongoing intensive

170 cruiting patients to compare CAS with EFD to carotid endarterectomy in different cohorts, such as pat

171 The effect of carotid endarterectomy in lowering the risk of stroke ip

172 is designed to look back over the history of carotid endarterectomy in order to understand the evolut

173 -artery stenting with embolic protection and carotid endarterectomy in patients 79 years of age or yo

174 protection") is an effective alternative to carotid endarterectomy in patients at average or high ri

175 The effect of carotid endarterectomy in patients who present with tran

176 d with a higher risk of stroke compared with carotid endarterectomy in patients with an ARWMC score o

177 s, but might be an acceptable alternative to carotid endarterectomy in patients with less extensive l

178 The authors determined whether carotid endarterectomy in patients with recurrent stenos

179 t differ between carotid artery stenting and carotid endarterectomy in patients with symptomatic and

180 may resolve the role of carotid stenting and carotid endarterectomy in primary and secondary stroke p

181 rotic plaques of patients undergoing primary carotid endarterectomy in the province of Utrecht from 2

182 has proven to be a potential alternative to carotid endarterectomy in the treatment of severe caroti

183 Carotid endarterectomy is associated with similar neurol

184 Carotid endarterectomy is more effective than medical ma

185 Carotid endarterectomy is now celebrating its 50th anniv

186 es where the balance of risk and benefit for carotid endarterectomy is particularly narrow, and to ex

187 While trials have demonstrated that carotid endarterectomy is superior to best medical thera

188 ing asymptomatic patients and treatment with carotid endarterectomy is unknown; the benefit is limite

189 Carotid artery stenting, compared with carotid endarterectomy, is emerging as an effective and

190 lerotic lesions from specimens obtained from carotid endarterectomies, lower limb amputations, and th

191 r elective abdominal aortic aneurysm repair, carotid endarterectomy, lower extremity arterial bypass

192 Carotid endarterectomy lowers the risk of carotid territ

193 patients with transient monocular blindness, carotid endarterectomy may be beneficial when other risk

194 the study, 937111 unique patients underwent carotid endarterectomy (mean age, 75.8 years; 43% women)

195 oke rates in patients without symptoms after carotid endarterectomy, medical therapy of asymptomatic

196 008, 2502 patients were randomly assigned to carotid endarterectomy (n=1240) or carotid artery stenti

197 ted with carotid artery stenting (n=2326) or carotid endarterectomy (n=2271) in 4 randomized trials b

198 the medical therapy-only group could undergo carotid endarterectomy only with substantial carotid art

199 arization, lower-extremity arterial disease, carotid endarterectomy or angioplasty, or abdominal aort

200 s) with the odds of procedural intervention (carotid endarterectomy or carotid artery stenting) compa

201 that was deemed equally suitable for either carotid endarterectomy or endovascular treatment were ra

202 cal practice, decision making with regard to carotid endarterectomy or stenting is still primarily ba

203 grafting (OR, 1.17; 95% CI, 1.05-1.29), and carotid endarterectomy (OR, 1.21; 95% CI, 1.04-1.40).

204 artery bypass surgery, coronary angioplasty, carotid endarterectomy, other cancer surgery, and orthop

205 ECST trials demonstrated the superiority of carotid endarterectomy over medical therapy in the preve

206 ), more invasive surgery (surgery other than carotid endarterectomy, p = 0.02), and impaired brachial

207 68.2%, P = 0.03); the effect was greatest in carotid endarterectomy patients (RB = 73.4% vs. no RB =

208 Carotid endarterectomy patients had a lower procedural s

209 additional 8 carotid artery stenting and 12 carotid endarterectomy patients had biomarker+ only (haz

210 revascularization, cerebrovascular accident, carotid endarterectomy, peripheral revascularization, ga

211 nopausal female with a history of stroke and carotid endarterectomy presented with 3 weeks of vaginal

212 Carotid endarterectomy presents a risk of myocardial inf

213 isolated coronary artery bypass grafting or carotid endarterectomy procedures performed for disease

214 Patients presenting for carotid endarterectomy provide anesthesiologists with ma

215 placement, abdominal aortic aneurysm repair, carotid endarterectomy, radical cystectomy, pancreatic r

216 Carotid endarterectomy rate during each month from 1989

217 Does intervention with carotid endarterectomy reduce morbidity or mortality?

218 In a meta-analysis, carotid endarterectomy reduced rates of 1) perioperative

219 Carotid endarterectomy reduces the risk of stroke in pat

220 cutaneous transluminal coronary angioplasty, carotid endarterectomy, reduction of femur fracture, tot

221 Carotid endarterectomy remains the standard of care for

222 Carotid endarterectomy remains the standard of care, eve

223 , including coronary artery bypass grafting, carotid endarterectomy, repair of nonruptured abdominal

224 Does screening or carotid endarterectomy result in harm?

225 d trials comparing filter-protected CAS with carotid endarterectomy revealed a higher periprocedural

226 00 expression in >70 samples obtained during carotid endarterectomy revealed that local miR-100 expre

227 xpressed in human atherosclerotic lesions in carotid endarterectomy samples (n = 18) but were not exp

228 single-cell RNA sequencing of advanced human carotid endarterectomy samples and compared these with s

229 que instability as seen in humans, and human carotid endarterectomy samples.

230 Ig repertoires were analyzed by RT-PCR in carotid endarterectomy samples.

231 and X-Act Stent in patients at high risk for Carotid Endarterectomy [SECuRITY]) have compared favorab

232 In the meantime, carotid endarterectomy should remain the treatment of ch

233 de, atherosclerotic plaques harvested during carotid endarterectomy show a time-dependent change in p

234 tegies among vascular patients scheduled for carotid endarterectomy significantly improved over the p

235 C. pneumoniae from a prospectively obtained carotid endarterectomy specimen.

236 Macrophage content was assessed in all carotid endarterectomy specimens as a percentage of CD68

237 ing agent versus control agent) and in human carotid endarterectomy specimens ex vivo (n=14; P<0.05).

238 Carotid endarterectomy specimens from 16 patients who we

239 lar matrix and associated molecules in human carotid endarterectomy specimens from 6 symptomatic vers

240 )F-NaF uptake was compared with histology in carotid endarterectomy specimens from patients with symp

241 Carotid endarterectomy specimens of 20 patients were inc

242 In human carotid endarterectomy specimens TLR7 levels were consis

243 (rho=0.721, P=0.019) in the 10 corresponding carotid endarterectomy specimens.

244 assessed by immunohistochemical staining of carotid endarterectomy specimens.

245 f SMC subsets in cultures derived from human carotid endarterectomy specimens.

246 msR4M-L1 binds to MIF in plaques from human carotid-endarterectomy specimens.

247 llenge the conclusions from the Asymptomatic Carotid Endarterectomy Study and the North American Symp

248 within atherosclerotic tissue at the time of carotid endarterectomy, suggesting that ozone production

249 In human plaques, collected during carotid endarterectomy surgery, we found that 14q32 micr

250 vascular event between 5 and 180 days of the carotid endarterectomy [symptomatic]) confirmed elevatio

251 In human plaques obtained by carotid endarterectomy, TF immunoreactivity (8+/-5% vers

252 Following emergent carotid endarterectomy, the patient's partial third-nerv

253 erative length of stay ranged from 3.4 days (carotid endarterectomy) to 19.6 days (esophagectomy).

254 e trials were the North American Symptomatic Carotid Endarterectomy Trial (NASCET clinical alert rele

255 The North American Symptomatic Carotid Endarterectomy Trial (NASCET) and the Asymptomat

256 The North American Symptomatic Carotid Endarterectomy Trial (NASCET) and the Asymptomat

257 9%) patients were North American Symptomatic Carotid Endarterectomy Trial (NASCET) eligible.

258 ould have met the North American Symptomatic Carotid Endarterectomy Trial (NASCET) entry criteria.

259 t stenosis by the North American Symptomatic Carotid Endarterectomy Trial (NASCET) method.

260 inclusion in the North American Symptomatic Carotid Endarterectomy Trial (NASCET).

261 s measured by the North American Symptomatic Carotid Endarterectomy Trial (NASCET).

262 omy Study and the North American Symptomatic Carotid Endarterectomy Trial regarding the benefits of C

263 ery Trial (ECST), North American Symptomatic Carotid Endarterectomy Trial, and Veterans Affairs trial

264 Surgery Trial and North American Symptomatic Carotid Endarterectomy Trial.

265 on data from the North American Symptomatic Carotid Endarterectomy Trial.

266 (>=2 mm, NASCET [North American Symptomatic Carotid Endarterectomy Trial] <70%).

267 mmense amount of data generated by the major carotid endarterectomy trials are defining particular su

268 Twenty patients scheduled for carotid endarterectomy underwent 3.0-T carotid MR imagin

269 Eighteen patients scheduled for carotid endarterectomy underwent a preoperative carotid

270 Twenty-two subjects who were scheduled for carotid endarterectomy underwent MRI with a 3-dimensiona

271 Fourteen patients scheduled for carotid endarterectomy underwent preoperative carotid MR

272 Thirty-four patients undergoing carotid endarterectomy underwent screening of carotid at

273 Thirty-day stroke and death rates from carotid endarterectomy vary from 2.7% to 4.7% in RCTs; h

274 In patients randomized to carotid endarterectomy versus carotid artery stenting, b

275 The RCTs of carotid endarterectomy versus medical treatment were con

276 trials (RCTs) of screening for CAS; RCTs of carotid endarterectomy versus medical treatment; systema

277 tid Atherosclerosis Study (ACAS) showed that carotid endarterectomy was beneficial for symptom-free p

278 carotid stenosis and high-risk features for carotid endarterectomy was conducted between April 2004

279 disease was confirmed by angiography before carotid endarterectomy was done.

280 Carotid endarterectomy was performed in 9,219 (94%) whit

281 METHODS AND Carotid endarterectomies were obtained from patients wit

282 ty-six laparoscopic cholecystectomies and 22 carotid endarterectomies were studied using direct obser

283 nt for carotid artery stenting compared with carotid endarterectomy were 6.2% versus 6.8% in men (haz

284 pothesis, 50 human specimens obtained during carotid endarterectomy were examined for the presence of

285 Twenty-six patients scheduled for carotid endarterectomy were imaged with a 1.5-T GE scann

286 (mean age 70 years; 54 males) scheduled for carotid endarterectomy were imaged with a 1.5-T scanner

287 Twenty-one patients scheduled for carotid endarterectomy were imaged with a 1.5-T scanner.

288 0% carotid artery stenosis and who underwent carotid endarterectomy were included in the study.

289 (mean age, 71 years; 49 male) scheduled for carotid endarterectomy were recruited after obtaining in

290 n; mean age +/- SD, 68.3 +/- 7.3) undergoing carotid endarterectomy were recruited for combined carot

291 tal of 20 consecutive patients scheduled for carotid endarterectomy were recruited to participate in

292 sts; and observational studies of harms from carotid endarterectomy were selected to answer the follo

293 attack, stroke, or amaurosis fugax), due for carotid endarterectomy, were prospectively recruited.

294 attack, stroke, or amaurosis fugax), due for carotid endarterectomy, were prospectively recruited.

295 of carotid artery stenting (CAS) relative to carotid endarterectomy when performed by physicians with

296 carotid artery stenting than those who have carotid endarterectomy whereas there is little differenc

297 carotid artery stenting (CAS) compared with carotid endarterectomy, which may differ in specific pat

298 ummarize the randomized trial data comparing carotid endarterectomy with carotid artery stenting and

299 omatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Car

300 Carotid endarterectomy without another concurrent surger

301 pothesis that high-risk patients can undergo carotid endarterectomy without associated increased risk